Browsing by Author "Oymak, E."
Now showing 1 - 14 of 14
- Results Per Page
- Sort Options
Item The Dosimetric Analysis & Clinical Outcomes of Contiguous Vertebrae SBRT in Oligometastatic Patients(2022) Guler, O. C.; Oymak, E.; Onal, C.Item The Effect of ADT on ADC Change in Intermediate-Risk Prostate Cancer Patients Receiving Radiotherapy(2023) Onal, C.; Erbay, G.; Oymak, E.; Guler, O. C.; 0000-0002-1706-8680; AAK-5370-2021Item The Effect of the Time Interval between Temozolomide and Radiotherapy in Adjuvant High-Grade Glioma Treatment(2022) Oymak, E.; Demircan, V.; Senyurek, S.; Yavas, G.; Guler, O. C.; Bolukbasi, Y.; Erpolat, P.; Onal, C.Item The impact of lymph node ratio in patients with stage IIIC endometrial carcinoma(2021) Onal, C.; Sari, S. Yuce; Yavas, G.; Guler, O. C.; Yigit, E.; Oymak, E.; Gultekin, M.; Yildiz, F.Item The Impact of the ADC for the Early Prediction of Treatment Response After Definitive Radiotherapy(2023) Onal, C.; Erbay, G.; Guler, O. C.; Oymak, E.; 0000-0002-1706-8680; AAK-5370-2021Item Interpreting Clinical Parameters and Nomograms for Predicting Lymph Node Metastasis Detected with 68 Ga-PSMAPET/CT in prostate cancer patients(2020) Onal, C.; Ozyigit, G.; Oymak, E.; Guler, O.C.; Hurmuz, P.; Tilki, B.; Torun, N.; Tuncel, M.; Reyhan, M.; Caglar, M.; Yapar, A.F.; Akyol, F.; 0000-0001-8550-3368; 0000-0002-2742-9021; 0000-0003-1715-4180; 0000-0001-6908-3412; 0000-0002-5597-676X; AAJ-5242-2021; D-5195-2014; AAI-8973-2021; AAC-5654-2020; AAE-2718-2021Item The Outcomes of Definitive Radiotherapy in Patients with Prostate Cancer Using Simultaneous Integrated Boost Technique(2022) Onal, C.; Guler, O. C.; Erbay, G.; Oymak, E.; Yavas, C.; Yavas, G.; 0000-0002-1706-8680; AAK-5370-2021Item Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival Following Stereotactic Ablative Radiation Therapy in Oligometastatic Castration-Sensitive Prostate Cancer(2022) Sutera, P.; Deek, M. P.; Guler, O. C.; Hurmuz, P.; Reyhan, M.; Rowe, S.; Hrinivich, W. T.; Ren, L.; Song, D.; Kiess, A. P.; Oymak, E.; Pienta, K.; Pomper, M. G.; Feng, F. Y.; Ozyigit, G.; Tran, P. T.; Phillips, R.; Onal, C.Item Re: Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease(2022) Onal, C.; Oymak, E.; Guler, O. C.; 34973870Item Response evaluation with 68GA-PSMA-PET/CT in prostate cancer patients treated with radiotherapy(2022) Onal, C.; Guler, O.; Oymak, E.; Torun, N.; Reyhan, M.Item SBRT and Tyrosine Kinase Inhibitors in Patients with Oligometastatic Renal Cell Carcinoma(2023) Onal, C.; Oymak, E.; Guler, O. C.; Tilki, B.; Yavas, G.; Hurmuz, P.; Yavas, C.; Ozyigit, G.Item The Treatment Outcomes of Patients with Cervical Esophageal Carcinoma Undergoing Definitive Chemoradiotherapy: A Multi-Institutional Analysis TROD 01-005(2022) Guler, O. C.; Oymak, E.; Yazici, G.; Akagunduz, O. Ozkaya; Cetinayak, O; Erpolat, P.; Aksoy, A.; Duzova, M.; Yildirim, B. Akkus; Kurt, M.; Canyilmaz, E.; Akyurek, S.; Atalar, B.; Yavas, G.; Oksuz, D. C.; Saglam, E. K.; Celik, O. Karakoyun; Cengiz, M.; Onal, C.; 0000-0002-5399-5430; AAA-1349-2022Item Treatment Outcomes of Simultaneous Integrated Boost to Intraprostatic Lesions with External Beam Radiotherapy in Localized Prostate Cancer Patients(2023) Onal, H. C.; Erbay, G.; Guler, O. C.; Yavas, C.; Oymak, E.; 37785393Item The Utility of Mean Apparent Diffusion Coefficient Value in Patients with Prostate Cancer Treated with Definitive Radiotherapy(2022) Onal, C.; Erbay, G.; Guler, O. C.; Oymak, E.; Yavas, C.; Yavas, G.; 0000-0002-1706-8680; AAK-5370-2021